274 related articles for article (PubMed ID: 10803753)
1. Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease.
Cheung HS
Curr Opin Rheumatol; 2000 May; 12(3):223-7. PubMed ID: 10803753
[TBL] [Abstract][Full Text] [Related]
2. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway.
Nair D; Misra RP; Sallis JD; Cheung HS
J Biol Chem; 1997 Jul; 272(30):18920-5. PubMed ID: 9228071
[TBL] [Abstract][Full Text] [Related]
3. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway.
Brogley MA; Cruz M; Cheung HS
J Cell Physiol; 1999 Aug; 180(2):215-24. PubMed ID: 10395291
[TBL] [Abstract][Full Text] [Related]
4. Calcium crystal deposition diseases: update on pathogenesis and manifestations.
Molloy ES; McCarthy GM
Rheum Dis Clin North Am; 2006 May; 32(2):383-400, vii. PubMed ID: 16716885
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells.
Liu R; O'Connell M; Johnson K; Pritzker K; Mackman N; Terkeltaub R
Arthritis Rheum; 2000 May; 43(5):1145-55. PubMed ID: 10817569
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor kappab, activator protein 1, and protein kinase c.
McCarthy GM; Augustine JA; Baldwin AS; Christopherson PA; Cheung HS; Westfall PR; Scheinman RI
J Biol Chem; 1998 Dec; 273(52):35161-9. PubMed ID: 9857053
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of pathogenic calcium crystals.
Lioté F; Ea HK
Curr Opin Rheumatol; 2014 Mar; 26(2):192-6. PubMed ID: 24452194
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2.
Molloy ES; Morgan MP; Doherty GA; McDonnell B; O'Byrne J; Fitzgerald DJ; McCarthy GM
Ann Rheum Dis; 2008 Dec; 67(12):1773-9. PubMed ID: 18223264
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of crystals within the joint.
Oliviero F; Scanu A; Punzi L
Reumatismo; 2012 Jan; 63(4):221-9. PubMed ID: 22303528
[TBL] [Abstract][Full Text] [Related]
10. Crystal deposition and osteoarthritis.
Olmez N; Schumacher HR
Curr Rheumatol Rep; 1999 Dec; 1(2):107-11. PubMed ID: 11123023
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.
Ariyoshi W; Okinaga T; Chaweewannakorn W; Akifusa S; Nisihara T
J Cell Physiol; 2017 Dec; 232(12):3481-3495. PubMed ID: 28105703
[TBL] [Abstract][Full Text] [Related]
12. Induction of matrix metalloproteinase-8 in human fibroblasts by basic calcium phosphate and calcium pyrophosphate dihydrate crystals: effect of phosphocitrate.
Reuben PM; Wenger L; Cruz M; Cheung HS
Connect Tissue Res; 2001; 42(1):1-12. PubMed ID: 11696984
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and tissue damage in crystal deposition diseases.
Dalbeth N; Haskard DO
Curr Opin Rheumatol; 2005 May; 17(3):314-8. PubMed ID: 15838243
[TBL] [Abstract][Full Text] [Related]
15. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
[TBL] [Abstract][Full Text] [Related]
16. [Effect of arteparon on the formation of calcium phosphate and calcium pyrophosphate crystals--comparative experimental study].
Sárközi AM; Németh-Csóka M
Z Rheumatol; 1984; 43(1):30-5. PubMed ID: 6324513
[TBL] [Abstract][Full Text] [Related]
17. The structural consequences of calcium crystal deposition.
Durcan L; Bolster F; Kavanagh EC; McCarthy GM
Rheum Dis Clin North Am; 2014 May; 40(2):311-28. PubMed ID: 24703349
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous crystal deposition in pseudogout.
Rothschild BM; Round MJ
JAMA; 1980 Nov; 244(18):2079-80. PubMed ID: 6253693
[TBL] [Abstract][Full Text] [Related]
19. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1.
Yokoo T; Kitamura M
Am J Physiol; 1996 Jan; 270(1 Pt 2):F123-30. PubMed ID: 8769830
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.
Rossant CJ; Pinnock RD; Hughes J; Hall MD; McNulty S
Endocrinology; 1999 Apr; 140(4):1525-36. PubMed ID: 10098484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
